ViStra Growth Partners, Inc. Signs Agreement to Consult Aventura Equities, Inc.

  CTD Holdings, Inc. (OTCBB: CTDH)
(FRANKFURT: CDJ) announced today that ViStra Growth Partners, Inc., a
wholly owned subsidiary of CTD Holdings, Inc., will begin its work in
earnest as an advisor to Aventura Equities, Inc. (PINKSHEETS: AVNE).

Under the agreement ViStra will receive restricted shares of common stock of Aventura and provide consulting services relating to corporate development initiatives, including prospective acquisitions and corporate structuring scenarios.

Frank Manzo, III, Chief Executive Officer of Aventura, commented, "After two years of reorganizing and cleaning up issues left by previous management, the Company is now positioned to expand its food and beverage distribution business and to structure strategic opportunities that are now available to the Company. I believe ViStra's expertise will provide Aventura the opportunity to capitalize effectively and quickly on several significant opportunities that have presented themselves to the Company."

Mr. Louis Weltman, Chief Executive of ViStra, stated, "Mr. Manzo has done a remarkable job consolidating distribution channels in the food and beverage industry. We can add significant tangible and intangible value to the Company and we look forward to working closely with Frank and the Company to make these opportunities become realities."

About ViStra Growth Partners, Inc.

ViStra is a consulting company providing corporate planning and growth strategies for private, start-up and micro-cap public companies. ViStra works with its clients to provide consulting services relating to business structure, organizational management, capital procurement, strategic acquisitions and investor communications. The company intends to focus on privately held corporations and start-ups, providing consulting services relating to business structure and accessing public capital markets. With its full suite of services, ViStra can be comprehensive in support of clients' needs. In addition the company provides lasting communication solutions for publicly traded companies.

About CTD Holdings, Inc.

The company is the one-stop shop, business-to-business facilitator of commercial and research applications of Cyclodextrins. With its branded Trappsol®, Aquaplex® and Cyclo(TM) product offerings, CTDH scientists coordinate the development of commercial products for use in many diverse industries that endeavor to put non water-soluble ingredients into water-based formulations or wish to create water soluble powdered products. More recently CTDH has worked, in an advisory capacity, on the benefits and application of Cyclodextrins as a treatment for Niemann Pick C disease, a debilitating childhood disease often called Childhood Alzheimer's. More information about the company is available on the company's website: www.cyclodex.com

This news release contains "forward-looking statements" that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that could cause future circumstances, events or results to differ materially from those projected in the forward-looking statements. CTDH is timely in the filing of its SEC mandated financial reports; these filings also contain forward-looking statements. The above forward-looking statements are made as of the date above; CTD Holdings, Inc accepts no specific responsibility for updating such statements.

Contact: Rick Strattan CEO 386-454-0887